SGLT2 inhibitor ameliorates hypertension by regulating the CYP4A/20-HETE pathway in the kidney
Targeting of MAD2L1 by miR-515-5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells
Urolithin A attenuates renal fibrosis by inhibiting TGF-β1/Smad and MAPK signaling pathways